Business
Jupiter Neurosciences Invited to Present Clinical and Commercial Progress at Investor Dinner at Mar-a-Lago
Jupiter Neurosciences, Inc. Jupiter Neurosciences Invited to Present Clinical and Commercial Progress at Investor Dinner at Mar-a-Lago JUPITER, FL, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) ("Jupiter" or the "Company"), a clinical-stage pharmaceutical company focused on neuroinflammation and central nervous system disorders, announces that members of senior management have been invited, as the only company this evening, to present its progress at a private inve
About this update from Jupiter Neurosciences, Inc.
[{"type":"image","alt":"Jupiter Neurosciences, Inc.","displaySize":"","headline":null,"caption":"Jupiter Neurosciences, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":89,"url":"https://media.zenfs.com/en/globenewswire.com/5207be81de89b7ef2fba669f8dd3e7f6"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/pYMq4mt4Y617fyJqYqyXSg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEyNTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/5207be81de89b7ef2fba669f8dd3e7f6","width":300,"height":89}},"lazy":false},{"type":"text","content":"Jupiter Neurosciences, Inc.","length":27,"tagName":"p"},{"type":"image","alt":"Jupiter Neurosciences Invited to Present Clinical and Commercial Progress at Investor Dinner at Mar-a-Lago","displaySize":"","headline":null,"caption":"Jupiter Neurosciences Invited to Present Clinical and Commercial Progress at Investor Dinner at Mar-a-Lago","credit":"GlobeNewswire Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":2048,"height":1253,"url":"https://media.zenfs.com/en/globenewswire.com/93e32d1e91afdceb0dbc7ee40b6ac6e8"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/y_CyStNmUuqZDOmk4W4ohQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTU4NztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/93e32d1e91afdceb0dbc7ee40b6ac6e8","width":960,"height":587},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/AaKki3ZatPVt1IOZpxWpCw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0xNDY4O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/93e32d1e91afdceb0dbc7ee40b6ac6e8","width":1200,"height":734}}},{"type":"text","content":"JUPITER, FL, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) ("Jupiter" or the "Company"), a clinical-stage pharmaceutical company focused on neuroinflammation and central nervous system disorders, announces that members of senior management have been invited, as the only company this evening, to present its progress at a private investor dinner taking place Wednesday, February 25, 2026 at 6:00 PM ET at The Mar-a-Lago Club in Palm Beach, Florida.","length":499,"tagName":"p"},{"type":"text","content":"The invitation-only event will convene a select group of accredited and high net worth investors for focused discussions on emerging investment opportunities. The event is being organized by the Money Channel NYC.","length":213,"...